Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms. by Hana M Dobrovolny, Catherine A A Beauchemin

Get full text

Correction: A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract. by Christian Quirouette, Nada P Younis, Micaela B Reddy, Catherine A A Beauchemin

Get full text

Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors. by Laura E Liao, Szymon Kowal, Daniel A Cardenas, Catherine A A Beauchemin

Get full text

Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses. by Catherine A A Beauchemin, Young-In Kim, Qin Yu, Giuseppe Ciaramella, John P DeVincenzo

Get full text

The effect of random virus failure following cell entry on infection outcome and the success of antiviral therapy by Christian Quirouette, Daniel Cresta, Jizhou Li, Kathleen P. Wilkie, Haozhao Liang, Catherine A. A. Beauchemin

Get full text

Assessing mathematical models of influenza infections using features of the immune response. by Hana M Dobrovolny, Micaela B Reddy, Mohamed A Kamal, Craig R Rayner, Catherine A A Beauchemin

Get full text

Quantifying mechanistic traits of influenza viral dynamics using in vitro data by Ada W.C. Yan, Jie Zhou, Catherine A.A. Beauchemin, Colin A. Russell, Wendy S. Barclay, Steven Riley

Get full text

Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility. by Eric G Paradis, Lady Tatiana Pinilla, Benjamin P Holder, Yacine Abed, Guy Boivin, Catherine A A Beauchemin

Get full text

Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. by Benjamin P Holder, Philippe Simon, Laura E Liao, Yacine Abed, Xavier Bouhy, Catherine A A Beauchemin, Guy Boivin

Get full text

Correction: Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration. by Daniel Cresta, Donald C Warren, Christian Quirouette, Amanda P Smith, Lindey C Lane, Amber M Smith, Catherine A A Beauchemin

Get full text

Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample's infection concentration. by Daniel Cresta, Donald C Warren, Christian Quirouette, Amanda P Smith, Lindey C Lane, Amber M Smith, Catherine A A Beauchemin

Get full text

Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1 by Karen Y.Y. Fung, Tse Wing Winnie Ho, Zizhen Xu, Dante Neculai, Catherine A.A. Beauchemin, Warren L. Lee, Gregory D. Fairn

Get full text

Quantification of Ebola virus replication kinetics in vitro. by Laura E Liao, Jonathan Carruthers, Sophie J Smither, CL4 Virology Team, Simon A Weller, Diane Williamson, Thomas R Laws, Isabel García-Dorival, Julian Hiscox, Benjamin P Holder, Catherine A A Beauchemin, Alan S Perelson, Martín López-García, Grant Lythe, John N Barr, Carmen Molina-París

Get full text